Next Article in Journal
A Validated HPLC/MS Limit Test Method for a Potential Genotoxic Impurity in Cilostazol and its Quantification in the API and in the Commercially Available Drug Product
Previous Article in Journal
Development and Validation of a Stability- Indicating RP-HPLC Method for the Assay of Pristinamycin in Bulk and Tablet Dosage Form
Article Menu

Article Versions

Export Article

Open AccessArticle
Sci. Pharm. 2015, 83(2), 243-267; doi:10.3797/scipharm.1408-10

Molecular Docking Studies of Phytocompounds from the Phyllanthus Species as Potential Chronic Pain Modulators

1
Department of Pharmacology and Pharmacognosy, Government College of Pharmacy, Karad, District Satara, 415124 Maharashtra, India.
2
Department of Pharmacology, Rajarambapu College of Pharmacy, Kasegaon, District-Sangli, 415404 Maharashtra, India.
3
Department of Pharmaceutical chemistry, Government College of Pharmacy, Karad, District Satara, 415124 Maharashtra, India.
*
Author to whom correspondence should be addressed.
Received: 16 August 2014 / Accepted: 8 November 2014 / Published: 8 November 2014
Download PDF [1086 KB, uploaded 7 September 2016]

Abstract

The study of inflammatory pain has been one of the most rapidly advancing and expanding areas of pain research in recent years. Studies from our lab have demonstrated the chronic pain-modulating potential of the Phyllanthus species and their probable interaction with various inflammatory mediators involving enzymes like COX-2 and PGE synthase, cytokines like TNF-alpha and IL-1 beta, and with the NMDA receptor. Inflammatory mediators which play a crucial role in chronic inflammatory hyperalgesia and its subsequent modulation were selected for their interactions with 86 structurally diverse phytoconstituents identified from the Phyllanthus species.
The docking analysis of the target proteins with the phytochemical ligands was performed using VLifeMDS software. The docking scores and analysis of the interactions of the phytocompounds with target proteins suggest that important molecules like lupeol, phyllanthin, hypopyllanthin, corilagin, epicatechin, and most of the other compounds have the ability to bind to multiple targets involved in inflammatory hyperalgesia.
Our study strongly suggests that the findings of the present study could be exploited in the future for designing ligands in order to obtain novel molecules for the treatment and management of chronic pain.
Keywords: InflammatoryPain; Docking; Phytochemical ligands; Phyllanthus InflammatoryPain; Docking; Phytochemical ligands; Phyllanthus
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

CHOPADE, A.R.; SAYYAD, F.J.; PORE, Y.V. Molecular Docking Studies of Phytocompounds from the Phyllanthus Species as Potential Chronic Pain Modulators. Sci. Pharm. 2015, 83, 243-267.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top